Cormorant Asset Management, LP
CIK 1583977 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $2.0B
- Posisi
- 50
- Per tanggal
- 30 Juni 2026
#1.535 dari 9.443 berdasarkan nilai 13F · top 16.3%
Nilai portofolio QoQ: -2.0% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 59,19%
- Bobot 25 kepemilikan teratas
- 89,52%
- Posisi di atas 1%
- 26
- Jumlah posisi efektif
- 21,7
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 14,19% Perkiraan pembelian $279.640.718 · penjualan $550.664.873
Kepemilikan median: 2,0 kuartal Dilacak Q4 2024–Q2 2026 · 52,6% masih dipegang
- Posisi baru
- 13
- Meningkat
- 4
- Menurun
- 28
- Tertutup
- 9
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
- Terkait Orang di balik pengaju ini, jika kami dapat mencocokkannya.
Kinerja vs S&P 500
Tahunan: +29.7% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 97,7% · Opsi dikecualikan: 4,1%
Rincian sektor
Healthcare
88,5%
Lainnya/Tidak terpetakan
11,5%
Portofolio lengkap 50 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $214.265.600 | 10,98% | 640.000 | $-71.033.645 | Turun ×5 | ||
| BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | $136.234.886 | 6,98% | 17.878.594 | $-23.778.530 | |||
| Penerbit tidak dikenal (CUSIP: 698955101) | $126.329.300 | 6,47% | 4.615.612 | Naik ×1 | |||
| RAPP Rapport Therapeutics, Inc. - Common Stock | $110.738.900 | 5,67% | 2.657.521 | $18.198.068 | Turun ×3 | ||
| ERAS Erasca, Inc. - Common Stock | $109.920.000 | 5,63% | 6.000.000 | $16.076.000 | Naik ×1 | ||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $101.981.300 | 5,23% | 2.510.000 | $-708.700 | Turun ×4 | ||
| EYPT EyePoint, Inc. - Common Stock | $100.100.000 | 5,13% | 7.000.000 | $-6.435.850 | Turun ×1 | ||
| ALMS Alumis Inc. - Common Stock | $92.456.671 | 4,74% | 3.285.596 | $5.454.892 | Turun ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $89.950.500 | 4,61% | 675.000 | $5.324.500 | Turun ×4 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $73.110.000 | 3,75% | 750.000 | $-6.614.000 | Turun ×1 | ||
| DRUG Bright Minds Biosciences Inc. - common stock | $63.180.000 | 3,24% | 900.000 | $-14.119.383 | Turun ×1 | ||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $62.409.781 | 3,20% | 3.205.433 | $-21.105.490 | Turun ×1 | ||
| BIOA BioAge Labs, Inc. - Common Stock | $58.593.729 | 3,00% | 2.390.605 | $8.037.048 | Turun ×1 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $50.757.968 | 2,60% | 533.340 | $24.597.641 | |||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $45.749.634 | 2,34% | 3.978.229 | $25.696.464 | Naik ×1 | ||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $40.964.000 | 2,10% | 550.000 | $-22.157.000 | Turun ×5 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $40.638.000 | 2,08% | 1.300.000 | $10.827.000 | Turun ×1 | ||
| BHVN Biohaven Ltd. Common Shares | $38.836.800 | 1,99% | 2.610.000 | $23.947.200 | Naik ×2 | ||
| AGMB AgomAb Therapeutics NV - ADRs representing one common share. | $32.000.217 | 1,64% | 2.465.348 | $6.138.716 | |||
| MBX MBX Biosciences, Inc. - Common Stock | $30.360.000 | 1,56% | 550.000 | $-3.072.000 | Turun ×1 | ||
| CLYM Climb Bio, Inc. - Common Stock | $27.462.240 | 1,41% | 2.106.000 | Naik ×1 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $26.896.500 | 1,38% | 2.150.000 | $-31.252.500 | Turun ×1 | ||
| GLTO Galecto, Inc. - Common Stock | $26.010.000 | 1,33% | 1.000.000 | $-13.487.500 | Turun ×1 | ||
| PHVS Pharvaris N.V. - Ordinary Shares | $25.935.000 | 1,33% | 750.000 | $-2.315.000 | Turun ×5 | ||
| CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $21.995.828 | 1,13% | 2.344.971 | $-23.450 | |||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $19.975.500 | 1,02% | 225.000 | Naik ×1 | |||
| DFTX Definium Therapeutics, Inc. - Common Shares | $18.816.000 | 0,96% | 400.000 | Naik ×1 | |||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $16.945.000 | 0,87% | 500.000 | $-13.464.500 | Turun ×3 | ||
| ROIV Roivant Sciences Ltd. - Common Shares | $16.810.250 | 0,86% | 475.000 | $-3.964.750 | Turun ×1 | ||
| CABA Cabaletta Bio, Inc. - Common Stock | $15.550.000 | 0,80% | 5.000.000 | $755.000 | Turun ×1 | ||
| HLXC Helix Acquisition Corp. III - Class A Ordinary Shares | $13.805.400 | 0,71% | 1.297.500 | $622.800 | |||
| Penerbit tidak dikenal (CUSIP: K08588103) | $13.336.000 | 0,68% | 50.000 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 482931102) | $12.116.500 | 0,62% | 550.000 | Naik ×1 | |||
| INSM Insmed Incorporated - Common Stock | $7.996.500 | 0,41% | 75.000 | $-23.072.300 | Turun ×4 | ||
| SNSE Sensei Biotherapeutics, Inc. - Common Stock | $7.655.550 | 0,39% | 1.028.242 | $-1.996.567 | Naik ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $7.612.500 | 0,39% | 150.000 | ||||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $6.294.000 | 0,32% | 100.000 | $-9.489.750 | Turun ×3 | ||
| IBIO iBio, Inc. - Common Stock | $6.247.500 | 0,32% | 3.570.000 | Naik ×1 | |||
| CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | $4.677.500 | 0,24% | 125.000 | $-4.402.500 | Turun ×3 | ||
| ARQT Arcutis Biotherapeutics, Inc. - Common stock | $4.588.500 | 0,24% | 175.000 | $-6.013.500 | Turun ×6 | ||
| ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | $4.075.500 | 0,21% | 50.000 | $-2.194.500 | Turun ×1 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $4.025.250 | 0,21% | 75.000 | $-4.409.750 | Turun ×1 | ||
| Penerbit tidak dikenal (CUSIP: G75226103) | $3.959.000 | 0,20% | 370.000 | Naik ×1 | |||
| COGT Cogent Biosciences, Inc. - Common Stock | $3.870.000 | 0,20% | 100.000 | $-3.828.000 | Turun ×2 | ||
| ALT Altimmune, Inc. - Common Stock | $3.800.000 | 0,19% | 1.250.000 | Naik ×1 | |||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $3.592.000 | 0,18% | 200.000 | $-1.273.000 | Turun ×3 | ||
| Penerbit tidak dikenal (CUSIP: 67613T104) | $3.274.250 | 0,17% | 175.000 | Naik ×1 | |||
| PCVX Vaxcyte, Inc. - Common Stock | $2.906.500 | 0,15% | 50.000 | $-2.904.500 | Turun ×3 | ||
| BOLD Boundless Bio, Inc. - Common Stock | $2.500.000 | 0,13% | 1.000.000 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 22053A305) | $100.009 | 0,01% | 5.498 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| Penerbit tidak dikenal (CUSIP: 698955101) | $126.329.300 | 4.615.612 | 6,47% |
| CLYM | $27.462.240 | 2.106.000 | 1,41% |
| SYRE | $19.975.500 | 225.000 | 1,02% |
| DFTX | $18.816.000 | 400.000 | 0,96% |
| Penerbit tidak dikenal (CUSIP: K08588103) | $13.336.000 | 50.000 | 0,68% |
| Penerbit tidak dikenal (CUSIP: 482931102) | $12.116.500 | 550.000 | 0,62% |
| ELVN | $7.612.500 | 150.000 | 0,39% |
| IBIO | $6.247.500 | 3.570.000 | 0,32% |
| Penerbit tidak dikenal (CUSIP: G75226103) | $3.959.000 | 370.000 | 0,20% |
| ALT | $3.800.000 | 1.250.000 | 0,19% |
| Penerbit tidak dikenal (CUSIP: 67613T104) | $3.274.250 | 175.000 | 0,17% |
| BOLD | $2.500.000 | 1.000.000 | 0,13% |
| Penerbit tidak dikenal (CUSIP: 22053A305) | $100.009 | 5.498 | 0,01% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| PRAX | Dipangkas | -246K | -$71.0M |
| OLMA | Dipangkas | -1.8M | -$31.3M |
| ANL | Beli lebih banyak | +1.1M | +$25.7M |
| ORKA | Hanya pergerakan harga | +0 | +$24.6M |
| BHVN | Beli lebih banyak | +850K | +$23.9M |
| BBOT | Hanya pergerakan harga | +0 | -$23.8M |
| INSM | Dipangkas | -115K | -$23.1M |
| BBIO | Dipangkas | -300K | -$22.2M |
| MLTX | Dipangkas | -1.3M | -$21.1M |
| RAPP | Dipangkas | -300K | +$18.2M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| QQQ | 31 Maret 2026 | 250.000 | $153.577.500 | |
| IWM | 31 Maret 2026 | 500.000 | $123.080.000 | Tidak lagi dilacak |
| XBI | 31 Maret 2026 | 1.000.000 | $121.930.000 | Tidak lagi dilacak |
| ACLX | 31 Des. 2025 | 775.000 | $63.627.500 | Tidak lagi dilacak |
| MRUS | 30 Sep. 2025 | 1.120.000 | $58.912.000 | Tidak lagi dilacak |
| CNTA | 30 Juni 2026 | 1.050.000 | $41.706.000 | Tidak lagi dilacak |
| ENGN | 31 Maret 2026 | 4.000.000 | $36.120.000 | -73,6% |
| VRNA | 30 Sep. 2025 | 350.000 | $33.103.000 | Tidak lagi dilacak |
| HLXB | 30 Sep. 2025 | 2.909.000 | $30.893.580 | Tidak lagi dilacak |
| CGON | 31 Des. 2025 | 625.000 | $25.175.000 | 88,5% |
| MAZE | 30 Juni 2026 | 750.000 | $22.387.500 | -2,6% |
| KRRO | 31 Des. 2025 | 465.000 | $22.268.850 | 66,5% |
| ASND | 30 Juni 2026 | 95.000 | $21.729.350 | -3,3% |
| MTSR | 31 Des. 2025 | 400.000 | $20.932.000 | Tidak lagi dilacak |
| SPRY | 30 Sep. 2025 | 1.100.000 | $19.195.000 | -44,5% |
| GHRS | 31 Maret 2026 | 1.300.000 | $16.510.000 | 105,7% |
| TERN | 30 Juni 2026 | 300.000 | $15.816.000 | Tidak lagi dilacak |
| AVBP | 31 Maret 2025 | 585.462 | $15.596.708 | 58,8% |
| CRGX | 30 Sep. 2025 | 3.381.277 | $13.930.861 | Tidak lagi dilacak |
| RNA | 31 Des. 2025 | 300.000 | $13.071.000 | -81,8% |
| SEPN | 31 Maret 2025 | 560.000 | $12.824.000 | 612,3% |
| AARD | 30 Sep. 2025 | 800.189 | $10.818.555 | -54,3% |
| JANX | 31 Maret 2026 | 650.000 | $8.970.000 | 26,5% |
| ZURA | 30 Juni 2026 | 1.450.000 | $8.627.500 | -1,0% |
| AXSM | 30 Juni 2026 | 50.000 | $8.451.000 | -14,8% |
| RYTM | 30 Juni 2025 | 150.000 | $7.945.500 | 73,7% |
| OKUR | 30 Juni 2025 | 1.837.739 | $7.902.278 | 66,1% |
| IBRX | 31 Maret 2025 | 3.000.000 | $7.680.000 | 162,5% |
| BMEA | 31 Des. 2025 | 3.570.872 | $7.213.161 | 10,5% |
| GLUE | 30 Juni 2026 | 400.000 | $6.580.000 | -38,4% |
| VYNE | 31 Maret 2025 | 1.394.336 | $4.671.026 | Tidak lagi dilacak |
| ELVN | 31 Des. 2025 | 200.000 | $4.094.000 | 285,5% |
| PLRX | 30 Juni 2025 | 3.000.000 | $4.050.000 | -3,4% |
| RLYB | 30 Juni 2026 | 400.000 | $3.588.000 | 4,8% |
| YMAB | 31 Maret 2025 | 425.000 | $3.327.750 | Tidak lagi dilacak |
| URGN | 31 Maret 2025 | 300.000 | $3.195.000 | 318,2% |
| OMER | 31 Maret 2025 | 300.000 | $2.964.000 | 128,1% |
| STOK | 30 Sep. 2025 | 254.161 | $2.884.727 | 35,2% |
| KALA | 30 Sep. 2025 | 603.027 | $2.870.409 | -44,1% |
| VYNE | 30 Sep. 2025 | 1.370.938 | $2.262.048 | Tidak lagi dilacak |
| VERV | 31 Maret 2025 | 350.000 | $1.974.000 | Tidak lagi dilacak |
| CNTX | 30 Juni 2026 | 529.550 | $1.387.421 | -3,1% |
| ARTV | 31 Maret 2025 | 103.633 | $1.044.621 | 278,7% |
| RAPT | 31 Maret 2025 | 200.000 | $316.000 | Tidak lagi dilacak |